Literature DB >> 24357686

Multicenter harmonization of 89Zr PET/CT performance.

Nikolaos E Makris1, Ronald Boellaard, Eric P Visser, Johan R de Jong, Bruno Vanderlinden, Roel Wierts, Berlinda J van der Veen, Henri J N M Greuter, Danielle J Vugts, Guus A M S van Dongen, Adriaan A Lammertsma, Marc C Huisman.   

Abstract

UNLABELLED: This study investigated the feasibility of quantitative accuracy and harmonized image quality in (89)Zr-PET/CT multicenter studies.
METHODS: Five PET/CT scanners from 3 vendors were included. (89)Zr activity was measured in a central dose calibrator before delivery. Local activity assays were based on volume as well as on the local dose calibrator. Accuracy and image noise were determined from a cross calibration experiment. Image quality was assessed from recovery coefficients derived from different volume-of-interest (VOI) methods (VOI A 50%, based on a 3-dimensional isocontour at 50% of the maximum voxel value with local background correction; VOI Max, based on the voxel with the highest uptake; and VOI 3Dpeak, based on a spheric VOI of 1.2-cm diameter positioned so as to maximize the enclosed average). PET images were analyzed before and after postreconstruction smoothing, applied to match image noise.
RESULTS: PET/CT accuracy and image noise ranged from -3% to 10% and from 13% to 22%, respectively. VOI 3Dpeak produced the most reproducible recovery coefficients. After calibration of the local dose calibrator to the central dose calibrator, differences between the local activity assays were within 6%.
CONCLUSION: This study showed that quantitative accuracy and harmonized image quality can be reached in (89)Zr PET/CT multicenter studies.

Keywords:  89Zr-PET; cross calibration; harmonization; image quality; multi-center

Mesh:

Substances:

Year:  2013        PMID: 24357686     DOI: 10.2967/jnumed.113.130112

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  31 in total

1.  Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scanner.

Authors:  Tyler J Bradshaw; Martin J Voorbach; David R Reuter; Anthony M Giamis; Sarah R Mudd; John D Beaver
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

2.  Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET/CT.

Authors:  Young Sub Lee; Jin Su Kim; Jung Young Kim; Byung Il Kim; Sang Moo Lim; Hee-Joung Kim
Journal:  Cancer Biother Radiopharm       Date:  2014-12-30       Impact factor: 3.099

Review 3.  Using PET for therapy monitoring in oncological clinical trials: challenges ahead.

Authors:  C M Deroose; S Stroobants; Y Liu; L K Shankar; P Bourguet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-27       Impact factor: 9.236

4.  A new colleague in nuclear medicine, the clinical technologist: quo vadis?

Authors:  Riemer H J A Slart; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07       Impact factor: 10.057

5.  Altered splenic [89Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?

Authors:  Human Adams; Bob Meek; Ewoudt Mw van de Garde; Coline Hm van Moorsel; Danielle J Vugts; Ruth G Keijsers; Jan C Grutters
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-08-25

6.  A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.

Authors:  Yaser Hadi Gholami; Hushan Yuan; Moses Q Wilks; Richard Maschmeyer; Marc D Normandin; Lee Josephson; Georges El Fakhri; Zdenka Kuncic
Journal:  Int J Nanomedicine       Date:  2020-02-24

7.  Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer.

Authors:  Idris Bahce; Marc C Huisman; Eline E Verwer; Rogier Ooijevaar; Firdaouss Boutkourt; Danielle J Vugts; Guus Ams van Dongen; Ronald Boellaard; Egbert F Smit
Journal:  EJNMMI Res       Date:  2014-08-02       Impact factor: 3.138

Review 8.  Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Authors:  Yvonne W S Jauw; C Willemien Menke-van der Houven van Oordt; Otto S Hoekstra; N Harry Hendrikse; Danielle J Vugts; Josée M Zijlstra; Marc C Huisman; Guus A M S van Dongen
Journal:  Front Pharmacol       Date:  2016-05-24       Impact factor: 5.810

9.  Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)I.

Authors:  Jakob W Kist; Manfred van der Vlies; Otto S Hoekstra; Henri N J M Greuter; Bart de Keizer; Marcel P M Stokkel; Wouter V Vogel; Marc C Huisman; Arthur van Lingen
Journal:  EJNMMI Res       Date:  2016-04-27       Impact factor: 3.138

10.  89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.

Authors:  Catharina Willemien Menke-van der Houven van Oordt; Elske C Gootjes; Marc C Huisman; Danielle J Vugts; Chantal Roth; Anne Marije Luik; Emma R Mulder; Robert C Schuit; Ronald Boellaard; Otto S Hoekstra; Guus Ams van Dongen; Henk M W Verheul
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.